Compare $CLYM vs $MDXG | Chartloom

Compare

$CLYM vs $MDXG

Climb Bio Inc · MiMedx Group Inc

CLYM

Climb Bio Inc

MDXG

MiMedx Group Inc

Compare $CLYM vs $MDXG

Comparing Climb Bio Inc and MiMedx Group Inc

CLYMClimb Bio Inc

MDXGMiMedx Group Inc

CLYMClimb Bio Inc

Market cap

$630M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

193.3%

52W performance

511.1%

FCF yield

-8.4%

MDXGMiMedx Group Inc

Market cap

$681M

P/E (TTM)

110.63x

Forward P/E (NTM)

130.81x

Forward P/S (NTM)

2.16x

Rev growth (TTM)

-2.4%

YTD performance

-27.9%

52W performance

-34.2%

FCF yield

6.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLYM

MDXG

Detailed metrics comparison

CLYM

Climb Bio Inc

MDXG

MiMedx Group Inc

Market Cap

CLYM$630M

MDXG$681M

Enterprise Value

CLYM$586M

MDXG$562M

Price

CLYM$11.00

MDXG$4.67

P/E Ratio

CLYMN/A

MDXG110.63x

P/S Ratio

CLYM0.00x

MDXG1.92x

EV/Sales

CLYM0.00x

MDXG1.58x

EV/EBITDA

CLYM0.00x

MDXG27.54x

P/B Ratio

CLYM2.62x

MDXG3.10x

P/FCF Ratio

CLYMN/A

MDXG15.32x

EV/FCF

CLYM-11.04x

MDXG12.65x

PEG Ratio

CLYMN/A

MDXGN/A

Forward P/E (NTM)

CLYMN/A

MDXG130.81x

Forward P/S (NTM)

CLYMN/A

MDXG2.16x

Revenue (TTM)

CLYM$0

MDXG$355M

Revenue Growth (YoY)

CLYMN/A

MDXG-2.4%

Forward Rev Growth

CLYM27.3%

MDXG22.1%

Gross Margin (TTM)

CLYM0.0%

MDXG78.8%

Operating Margin (TTM)

CLYM0.0%

MDXG2.5%

EBITDA Margin (TTM)

CLYM0.0%

MDXG5.7%

Net Margin (TTM)

CLYM0.0%

MDXG1.8%

FCF Margin (TTM)

CLYMN/A

MDXG12.5%

Net Income (TTM)

CLYM$-58M

MDXG$6M

FCF (TTM)

CLYM$-53M

MDXG$44M

EPS (TTM)

CLYM-$0.76

MDXG$0.04

ROE (TTM)

CLYM-3179.0%

MDXG2.6%

ROA (TTM)

CLYM-3079.0%

MDXG2.0%

ROIC (TTM)

CLYM-3179.0%

MDXG2.4%

Cash

CLYM$44M

MDXG$136M

Debt

CLYM$0

MDXG$17M

Net Cash/Debt

CLYM$44M

MDXG$119M

Current Ratio (TTM)

CLYM31.45x

MDXG5.33x

Quick Ratio (TTM)

CLYM30.86x

MDXG4.79x

Debt/Equity (TTM)

CLYM0.00x

MDXG0.08x

Debt/Assets (TTM)

CLYM0.0%

MDXG0.0%

Interest Coverage (TTM)

CLYMN/A

MDXGN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

MDXG0.00x

Beta

CLYM-0.01

MDXG1.20

52W Performance

CLYM511.1%

MDXG-34.2%

YTD Performance

CLYM193.3%

MDXG-27.9%

% from 52W High

CLYM-40.0%

MDXG-41.4%

% from 52W Low

CLYM572.8%

MDXG54.1%

Asset Turnover (TTM)

CLYM0.00x

MDXG1.14x

FCF Yield (TTM)

CLYM-8.4%

MDXG6.5%

Earnings Yield (TTM)

CLYM-9.1%

MDXG0.9%

Dividend Yield (TTM)

CLYMN/A

MDXGN/A

Rule of 40

CLYM0.0

MDXG10.1

EV/GP/RG

CLYMN/A

MDXG0.09

Ticker research

View CLYM research View MDXG research

Metric	CLYM Climb Bio Inc	MDXG MiMedx Group Inc
Market & Valuation
Market Cap	$630M	$681M
Enterprise Value	$586M	$562M
Price	$11.00	$4.67
P/E Ratio	N/A	110.63x
P/S Ratio	0.00x	1.92x
EV/Sales	0.00x	1.58x
EV/EBITDA	0.00x	27.54x
P/B Ratio	2.62x	3.10x
P/FCF Ratio	N/A	15.32x
EV/FCF	-11.04x	12.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	130.81x
Forward P/S (NTM)	N/A	2.16x
Revenue & Growth
Revenue (TTM)	$0	$355M
Revenue Growth (YoY)	N/A	-2.4%
Forward Rev Growth	27.3%	22.1%
Profitability
Gross Margin (TTM)	0.0%	78.8%
Operating Margin (TTM)	0.0%	2.5%
EBITDA Margin (TTM)	0.0%	5.7%
Net Margin (TTM)	0.0%	1.8%
FCF Margin (TTM)	N/A	12.5%
Net Income (TTM)	$-58M	$6M
FCF (TTM)	$-53M	$44M
EPS (TTM)	-$0.76	$0.04
ROE (TTM)	-3179.0%	2.6%
ROA (TTM)	-3079.0%	2.0%
ROIC (TTM)	-3179.0%	2.4%
Financial Health
Cash	$44M	$136M
Debt	$0	$17M
Net Cash/Debt	$44M	$119M
Current Ratio (TTM)	31.45x	5.33x
Quick Ratio (TTM)	30.86x	4.79x
Debt/Equity (TTM)	0.00x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	1.20
52W Performance	511.1%	-34.2%
YTD Performance	193.3%	-27.9%
% from 52W High	-40.0%	-41.4%
% from 52W Low	572.8%	54.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.14x
FCF Yield (TTM)	-8.4%	6.5%
Earnings Yield (TTM)	-9.1%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	10.1
EV/GP/RG	N/A	0.09
Ticker research	View CLYM research	View MDXG research

Valuation

P/E Ratio

MDXG

110.63x

P/S Ratio

CLYM

0.00x

MDXG

1.92x

EV/FCF

CLYM

-11.04x

MDXG

12.65x

Growth & revenue

Revenue Growth TTM

MDXG

-2.4%

Forward Revenue Growth

CLYM

27.3%

MDXG

22.1%

Profitability & performance

Gross Margin

MDXG

78.8%

CLYM

0.0%

ROE

MDXG

2.6%

CLYM

-3179.0%

FCF Yield %

MDXG

6.5%

CLYM

-8.4%

52-Week Performance

CLYM

511.1%

MDXG

-34.2%

Detailed metrics comparison

CLYM

Climb Bio Inc

MDXG

MiMedx Group Inc

Market Cap

CLYM$630M

MDXG$681M

Enterprise Value

CLYM$586M

MDXG$562M

Price

CLYM$11.00

MDXG$4.67

P/E Ratio

CLYMN/A

MDXG110.63x

P/S Ratio

CLYM0.00x

MDXG1.92x

EV/Sales

CLYM0.00x

MDXG1.58x

EV/EBITDA

CLYM0.00x

MDXG27.54x

P/B Ratio

CLYM2.62x

MDXG3.10x

P/FCF Ratio

CLYMN/A

MDXG15.32x

EV/FCF

CLYM-11.04x

MDXG12.65x

PEG Ratio

CLYMN/A

MDXGN/A

Forward P/E (NTM)

CLYMN/A

MDXG130.81x

Forward P/S (NTM)

CLYMN/A

MDXG2.16x

Revenue (TTM)

CLYM$0

MDXG$355M

Revenue Growth (YoY)

CLYMN/A

MDXG-2.4%

Forward Rev Growth

CLYM27.3%

MDXG22.1%

Gross Margin (TTM)

CLYM0.0%

MDXG78.8%

Operating Margin (TTM)

CLYM0.0%

MDXG2.5%

EBITDA Margin (TTM)

CLYM0.0%

MDXG5.7%

Net Margin (TTM)

CLYM0.0%

MDXG1.8%

FCF Margin (TTM)

CLYMN/A

MDXG12.5%

Net Income (TTM)

CLYM$-58M

MDXG$6M

FCF (TTM)

CLYM$-53M

MDXG$44M

EPS (TTM)

CLYM-$0.76

MDXG$0.04

ROE (TTM)

CLYM-3179.0%

MDXG2.6%

ROA (TTM)

CLYM-3079.0%

MDXG2.0%

ROIC (TTM)

CLYM-3179.0%

MDXG2.4%

Cash

CLYM$44M

MDXG$136M

Debt

CLYM$0

MDXG$17M

Net Cash/Debt

CLYM$44M

MDXG$119M

Current Ratio (TTM)

CLYM31.45x

MDXG5.33x

Quick Ratio (TTM)

CLYM30.86x

MDXG4.79x

Debt/Equity (TTM)

CLYM0.00x

MDXG0.08x

Debt/Assets (TTM)

CLYM0.0%

MDXG0.0%

Interest Coverage (TTM)

CLYMN/A

MDXGN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

MDXG0.00x

Beta

CLYM-0.01

MDXG1.20

52W Performance

CLYM511.1%

MDXG-34.2%

YTD Performance

CLYM193.3%

MDXG-27.9%

% from 52W High

CLYM-40.0%

MDXG-41.4%

% from 52W Low

CLYM572.8%

MDXG54.1%

Asset Turnover (TTM)

CLYM0.00x

MDXG1.14x

FCF Yield (TTM)

CLYM-8.4%

MDXG6.5%

Earnings Yield (TTM)

CLYM-9.1%

MDXG0.9%

Dividend Yield (TTM)

CLYMN/A

MDXGN/A

Rule of 40

CLYM0.0

MDXG10.1

EV/GP/RG

CLYMN/A

MDXG0.09

Ticker research

View CLYM research View MDXG research

Metric	CLYM Climb Bio Inc	MDXG MiMedx Group Inc
Market & Valuation
Market Cap	$630M	$681M
Enterprise Value	$586M	$562M
Price	$11.00	$4.67
P/E Ratio	N/A	110.63x
P/S Ratio	0.00x	1.92x
EV/Sales	0.00x	1.58x
EV/EBITDA	0.00x	27.54x
P/B Ratio	2.62x	3.10x
P/FCF Ratio	N/A	15.32x
EV/FCF	-11.04x	12.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	130.81x
Forward P/S (NTM)	N/A	2.16x
Revenue & Growth
Revenue (TTM)	$0	$355M
Revenue Growth (YoY)	N/A	-2.4%
Forward Rev Growth	27.3%	22.1%
Profitability
Gross Margin (TTM)	0.0%	78.8%
Operating Margin (TTM)	0.0%	2.5%
EBITDA Margin (TTM)	0.0%	5.7%
Net Margin (TTM)	0.0%	1.8%
FCF Margin (TTM)	N/A	12.5%
Net Income (TTM)	$-58M	$6M
FCF (TTM)	$-53M	$44M
EPS (TTM)	-$0.76	$0.04
ROE (TTM)	-3179.0%	2.6%
ROA (TTM)	-3079.0%	2.0%
ROIC (TTM)	-3179.0%	2.4%
Financial Health
Cash	$44M	$136M
Debt	$0	$17M
Net Cash/Debt	$44M	$119M
Current Ratio (TTM)	31.45x	5.33x
Quick Ratio (TTM)	30.86x	4.79x
Debt/Equity (TTM)	0.00x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	1.20
52W Performance	511.1%	-34.2%
YTD Performance	193.3%	-27.9%
% from 52W High	-40.0%	-41.4%
% from 52W Low	572.8%	54.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.14x
FCF Yield (TTM)	-8.4%	6.5%
Earnings Yield (TTM)	-9.1%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	10.1
EV/GP/RG	N/A	0.09
Ticker research	View CLYM research	View MDXG research